Search results for "Dosis"

showing 10 items of 369 documents

Caractérisation des figures myéliniques associées à l'accumulation de lipides polaires induites par différents oxystérols cytotoxiques identifiés dan…

2006

Atherosclerosis is a complex and chronic arterial process which is characterized by a remodeling of the vascular wall, associated with inflammatory reactions, proliferation and cell death process, and with accumulation of oxidized lipids among which oxysterols (cholesterol oxidation products) which might play key roles in the initiation and development of atheromatous lesions. Our work performed on U937 and THP1 promonocytic cells, rat aorta embryonic A7R5 cells, and breast carcinoma MCF7 cells (caspase-3 deficient). Different oxysterols, present in large quantity in atheromatous lesions, were used: 7-cétocholestérol (7KC), 7Β-hydroxycholestérol, 25-hydroxycholestérol, cholestérol-5Α, 6Α-ep…

AthéroscléroseCell DeathApoptose[ SDV.BC ] Life Sciences [q-bio]/Cellular BiologyLipidesApoptosisOxystérolsAtherosclerosisLipidsPhospholipidosisPhospholipidose<br />Vitamine-ECaspase-2[ SDV.BBM.BC ] Life Sciences [q-bio]/Biochemistry Molecular Biology/Biomolecules [q-bio.BM]Mort cellulaireVitamin E[SDV.BBM.BC] Life Sciences [q-bio]/Biochemistry Molecular Biology/Biochemistry [q-bio.BM][SDV.BC] Life Sciences [q-bio]/Cellular Biology
researchProduct

Proteomic analysis of Kveim reagent identifies targets of cellular immunity in sarcoidosis

2017

Background Kveim-reagent (Kv) skin testing was a historical method of diagnosing sarcoidosis. Intradermal injection of treated sarcoidosis spleen tissue resulted in a granuloma response at injection site by 4–6 weeks. Previous work indicates proteins as the possible trigger of this reaction. We aimed to identify Kv-specific proteins and characterise the ex vivo response of Peripheral Blood Mononuclear Cells (PBMCs) from sarcoidosis, tuberculosis and healthy control patients when stimulated with both Kv and selected Kv-specific proteins. Methods Kv extracts were separated by 1D-SDS-PAGE and 2D-DIGE and then underwent mass spectrometric analysis for protein identification. Sarcoidosis and con…

Bacterial DiseasesMaleProteomics0301 basic medicineCellular immunityPhysiologylcsh:MedicineVimentinBiochemistry0302 clinical medicineTandem Mass SpectrometryImmune PhysiologyMedicine and Health SciencesMedicinelcsh:ScienceCITRULLINATED VIMENTINInnate Immune SystemImmunity CellularMultidisciplinarybiologyMYCOBACTERIAL CATALASE-PEROXIDASEPEPTIDESMiddle Aged3. Good healthMultidisciplinary SciencesInfectious DiseasesGranulomaCytokinesScience & Technology - Other TopicsElectrophoresis Polyacrylamide GelFemaleResearch ArticleAdultSarcoidosisGeneral Science & TechnologyInflammatory DiseasesSYSTEMIC SARCOIDOSISImmunologyANTIGENTUBERCULOSISPeripheral blood mononuclear cell03 medical and health sciencesImmune systemRheumatologyAntigenMD MultidisciplinaryVimentinHumansSecretionScience & Technologybusiness.industrylcsh:RBiology and Life SciencesProteinsMolecular DevelopmentTropical Diseasesmedicine.diseaseRHEUMATOID-ARTHRITISCytoskeletal Proteins030104 developmental biology030228 respiratory systemImmune SystemImmunologybiology.proteinT-CELLSIndicators and Reagentslcsh:QCytokine secretionBODIESPhysiological ProcessesbusinessSpleenEx vivoDevelopmental BiologyRCRESPONSES
researchProduct

Oxygenation and Bioenergetic Status of Murine Fibrosarcomas

1992

The heterogeneity of cellular response to therapy is a major problem in non-surgical cancer therapy. This heterogeneity is influenced by both the genetic variability between different tumor cells and by epigenetic, physiological factors, such as the local metabolic milieu. A restriction of tumor microcirculation concomitant with regional hypoxia, nutrient depletion, accumulation of lactate, and an intensified tumor acidosis becomes evident during growth of many solid tumors1. These critical factors can greatly influence the efficiency of various non-surgical tumor therapies.

BioenergeticsCritical factorsmedicineCancer therapyCancer researchGenetic variabilityEpigeneticsOxygenationmedicine.symptomBiologyHypoxia (medical)Acidosis
researchProduct

Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts.

1977

Abstract Extracts of fibroblasts derived from a patient with mucolipidosis I exhibited a fivefold increase in sialic acid content as compared to those of normal cells. About 80% of this sialic acid was linked to other molecules. Using neuraminlactose as a substrate, mucolipidosis I fibroblasts were found to be severely deficient in an “acid” α-N-acetylneuraminidase. Since other lysosomal hydrolase activities were normal, we hypothesize that the basic metabolic lesion in mucolipidosis I lies in a defective degradation of sialic acid-containing compounds due to the genetic deficiency of a neuraminidase.

BiophysicsNeuraminidaseBiochemistryLesionchemistry.chemical_compoundMucolipidosesMucolipidosis IHydrolasemedicineHumansSialidosisMolecular BiologyCells CulturedSkinbiologyMucolipidosesSubstrate (chemistry)Cell BiologyFibroblastsmedicine.diseaseSialic acidBiochemistrychemistrybiology.proteinSialic Acidsmedicine.symptomNeuraminidaseBiochemical and biophysical research communications
researchProduct

A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury

2016

AbstractIn preclinical stages of drug development, anticipating potential adverse drug effects such as toxicity is an important issue for both saving resources and preventing public health risks. Current in vitro cytotoxicity tests are restricted by their predictive potential and their ability to provide mechanistic information. This study aimed to develop a metabolomic mass spectrometry-based approach for the detection and classification of drug-induced hepatotoxicity. To this end, the metabolite profiles of human derived hepatic cells (i.e., HepG2) exposed to different well-known hepatotoxic compounds acting through different mechanisms (i.e., oxidative stress, steatosis, phospholipidosis…

Bioquímica0301 basic medicineDrugmedia_common.quotation_subjectMetaboliteBiologyPharmacologymedicine.disease_causeBioinformaticsModels BiologicalArticleMass Spectrometry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMetabolomicsmedicineHumansMetabolomicsToxicologiaPhospholipidsmedia_commonPhospholipidosisMultidisciplinaryHep G2 Cellsmedicine.diseaseGlutathioneFatty LiverOxidative Stress030104 developmental biologychemistryDrug development030220 oncology & carcinogenesisToxicityChemical and Drug Induced Liver InjurySteatosisOxidative stressScientific Reports
researchProduct

A Worldwide Perspective on COVID-19 and Diabetes Management in 22,820 Children from the SWEET Project: Diabetic Ketoacidosis Rates Increase and Glyce…

2021

Aims: To investigate the short-term effects of the first wave of COVID-19 on clinical parameters in children with type 1 diabetes (T1D) from 82 worldwide centers participating in the Better Control in Pediatric and Adolescent DiabeteS: Working to CrEate CEnTers of Reference (SWEET) registry. Materials and Methods: Aggregated data per person with T1D £21 years of age were compared between May/June 2020 (first wave), August/September 2020 (after wave), and the same periods in 2019. Hierarchic linear and logistic regression models were applied. Models were adjusted for gender, age-, and diabetes duration-groups. To distinguish the added burden of the COVID-19 pandemic, the centers were divided…

Blood GlucoseMale2019-20 coronavirus outbreakPediatricsmedicine.medical_specialtyHbA1cAdolescentCoronavirus disease 2019 (COVID-19)Diabetic ketoacidosisEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)030209 endocrinology & metabolismGlycemic Control03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes managementDiabetic ketoacidosisDiabetes mellitusHumansMedicine030212 general & internal medicineChildPandemicsChildrenGlycemicGlycated HemoglobinType 1 diabetesbusiness.industryCGMBlood Glucose Self-MonitoringCOVID-19CSIIBMI.medicine.diseaseMedical Laboratory TechnologyDiabetes Mellitus Type 1Type 1 diabetesFemalebusinessDiabetes Technology & Therapeutics
researchProduct

Microregional distributions of glucose, lactate, ATP and tissue pH in experimental tumours upon local hyperthermia and/or hyperglycaemia

1993

Microregional distributions of glucose, lactate and ATP concentrations as well as tissue pH values were determined in subcutaneous rat tumours during normothermia and normoglycaemia, and upon local hyperthermia (HT) and/or hyperglycaemia (HG). Experiments were performed in order to investigate whether, and to what extent, these adjuvant therapeutic measures applied alone or in combination can modify the bioenergetic and metabolic status, parameters that are known to markedly influence the therapeutic response of tumours to heat. Local HT was performed in a saline bath (44 degrees C/2 h) and HG was induced by i.v. infusion of glucose for 2.5 h (blood glucose levels during heating: 35-40 mM).…

Blood GlucoseMaleHyperthermiaCancer Researchmedicine.medical_specialtyBioenergeticsmedicine.medical_treatmentBiologyRats Sprague-DawleyAdenosine TriphosphateInternal medicinemedicineAnimalsLactic AcidSalineAcidosisGlucose tolerance testmedicine.diagnostic_testHyperthermia InducedGeneral MedicineMetabolismHydrogen-Ion Concentrationmedicine.diseaseRatsGlucoseEndocrinologyOncologyMechanism of actionHyperglycemiaLactatesCrabtree effectSarcoma Experimentalmedicine.symptomJournal of Cancer Research and Clinical Oncology
researchProduct

Protective action of 1,3-butanediol in cerebral ischemia. A neurologic, histologic, and metabolic study.

1987

1,3-Butanediol (BD) is converted in the body to β-hydroxybutyrate, and previous studies have shown that hyperketonemia had beneficial effects in experimental models of generalized hypoxia. The aim of this study was to determine if BD would reduce brain damage following cerebral ischemia. A transient forebrain ischemia of 30-min duration was induced by the four-vessel occlusion technique in control and BD-treated rats (25 mmol/kg, i.p.; 30 min prior to ischemia). BD treatment led to significant improvement of neurologic deficit during the 72-h recovery period and reduced neuronal damage in the striatum and cortex but not in the CA1 sector of the hippocampus. Evaluation of cerebral energy me…

Blood GlucoseMalemedicine.medical_specialtyIschemiaHydroxybutyratesBlood PressureBrain damageHippocampusPhosphocreatinechemistry.chemical_compoundInternal medicinemedicine13-ButanediolAnimalsEnergy chargeButylene GlycolsCerebral CortexNeurons3-Hydroxybutyric Acidbusiness.industryBrainHypoxia (medical)medicine.diseaseCorpus StriatumRatsEndocrinologyNeurologychemistryIschemic Attack TransientLactic acidosisKetone bodiesNeurology (clinical)medicine.symptomCardiology and Cardiovascular MedicinebusinessEnergy MetabolismJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
researchProduct

Fasting prior to transient cerebral ischemia reduces delayed neuronal necrosis.

1990

A transient brain ischemia of 30-min duration was induced by the four-vessel occlusion technique in normally fed and in 48-hr-fasted rats. Evaluation of brain damage 72 hr after ischemia showed that fasting reduced neuronal necrosis in the striatum, the neocortex, and the lateral part of the CA1 sector of hippocampus. Signs of status spongiosis in the pars reticulata of the substantia nigra were seen in 75% of fed rats and in only 19% of fasted rats. The protective effect was associated with reduction in mortality and in postischemic seizure incidence. The metabolic changes induced by fasting were evaluated before and during ischemia. After 30 min of four-vessel occlusion, fasted rats showe…

Blood GlucoseMalemedicine.medical_specialtyIschemiaHydroxybutyratesSubstantia nigraBlood PressureBrain damageBiochemistryBrain ischemiaCellular and Molecular Neurosciencechemistry.chemical_compoundNecrosisReference ValuesInternal medicinemedicineAnimalsNeuronsGlycogen3-Hydroxybutyric Acidbusiness.industryAdenine NucleotidesBrainRats Inbred StrainsFastingmedicine.diseaseRatsEndocrinologyGlucosechemistryIschemic Attack TransientOrgan SpecificityLactic acidosisAnesthesiaKetone bodiesLactatesNeurology (clinical)medicine.symptomPars reticulatabusinessEnergy MetabolismMetabolic brain disease
researchProduct

The diabetic ketoacidosis

2014

The Diabetic Ketoacidosis (DKA) is still today a medical emergency in pediatrics. Despite the latest great sensibilization of the population and the doctors, the risk of DKA has not yet been eliminated and this pathology is still occurring in 25 to 40% of diabetes onset cases, in already diagnosed patients with poor compliance (10%), in patients undergoing acute medical or surgical events or in patients in Continuous Subcoutaneous Insulin Therapy (CSII). In toddlers (0-3 years) it is twice more frequent than in the following ages and is characterized by the presence of more serious clinical dehydratation (>10%) and neurological signs (obnubilation 40%). The other category at risk is represe…

Body surface areaeducation.field_of_studyPediatricsmedicine.medical_specialtyDiabetic ketoacidosisbusiness.industryInsulinmedicine.medical_treatmentPopulationMetabolic acidosismedicine.diseaseDiabetes mellitusMeeting AbstractmedicineRegular insulineducationComplicationbusinessItalian Journal of Pediatrics
researchProduct